Occurrence of anti-C1q antibodies in IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 12, Issue 11, 1997, Pages 2263-2268

  Gunnarsson, I ^a   Ronnelid J ^a   Lundberg, I ^a   Jacobson, S H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anti C1q antibodies; Complement; Idiopathic membranous glomerulonephritis; IgA nephropathy; Minimal change disease; SLE nephritis

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATURIA; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA;

ADOLESCENT; ADULT; AGED; ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; COMPLEMENT C1Q; DNA; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED;

EID: 0030719935     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.11.2263     Document Type: Article

References (35)

1. Ibels LS, Györy AZ. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease and review of the literature. Medicine 1994; 73: 79-102
2. Hall RP, Stachura I, Cason J, Whiteside TL, Lawley TJ. IgA-containing circulating immune complexes in patients with IgA nephropathy. Am J Med 1983; 74: 56-63
3. Wyatt RJ, Julian BA. Activation of complement in IgA nephropathy. Am J Kidney Dis 1988; 5: 437-442
4. Evans DJ, Williams DG, Peters DK et al. Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis, Br Med J 1973; 3: 326-328
5. Miyazaki R, Kuroda M, Akiyama T, Otani I, Tofuku Y, Takeda R. Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy. Clin Nephrol 1984; 21: 335-340
6. Burritt MF, Calvanico J, Metha S, Tomasi TB Jr. Activation of the classical pathway by Fc fragment of human IgA. J Immunol 1977; 118: 723-725
7. Lavö B, Nilsson B, Lööf L, Nilsson UR, Nilsson Ekdahl K. Fc receptor function and circulating immune complexes in gluten sensitive enteropathy - possible significance of IgA. Gut 1991; 32: 876-880
8. Appel EB, Silva FG, Pirani CL, Meltzer JI. Estes D. Renal involvement in systemic lupus erythematosus (SLE): a study of 56 patients emphasizing histologic classification. Medicine 1978; 75: 371-410
9. Davies KA, Peters AM, Beynon HL, Walport MJ. Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies. J Clin Invest 1992; 90: 2075-2083
10. Cattran DC, Chodirker WB. Experimental membranous glomerulonephritis. The relationship between circulating free antibody and immune complexes to subsequent pathology. Nephron 1982; 31: 260-265
11. Uwatoko S, Aotsuka S, Okawa M et al. Characterization of C1q-binding IgG complexes in systemic lupus erythematosus. Clin Immunol Immunopathol 1984; 30: 104-116
12. Wisnieski JJ, Jones SN. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J Immunol 1992; 148: 1396-1403
13. Siegert CEH, Daha MR, van der Voort EAM, Breedveld FC. IgG and IgA antibodies to the collagen-like region of C1q in rheumatoid vasculitis. Arthritis Rheum 1990; 33: 1646-1654
14. Siegert CEH, Daha MR. Halma C, van der Voort EAM, Breedveld FC. IgG and IgA autoantibodies to C1q in systemic and renal disorders. Clin Exp Rheumatol 1992; 10: 19-23
15. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277
16. Churg J, Sobin LH. Renal Disease, Classification and Atlas of Glomerular Diseases. Igaku-Shoin, Tokyo/New York, 1982
17. Rönnelid J, Huang YH, Norrlander T et al. Short-term kinetics of the humoral anti-C1q response in SLE using the ELISPOT method: fast decline in production in response to steroids. Scand J Immunol 1994; 40: 243-350
18. Gunnarsson I, Rönnelid J, Huang YH et al. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active SLE. Br J Rheum 1997; 36: 32-37
19. Mollnes TE, Lea T, Fröland SS, Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 1985; 22: 197-202
20. Nilsson Ekdahl K, Nilsson B, Pekna M, Nilsson UR. Generation of iC3 at the surface between blood and gas. Scand J Immunol 1992; 35: 85-91
21. Siegert CE, Daha MR, Tseng CM et al. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann Rheum Dis 1993; 52: 851-856
22. Strife CF, Leahy AE, West CD. Antibody to a cryptic, solidphase C1q antigen in membranoproliferative nephritis. Kidney Int 1989; 35: 836-842
23. Uwatoko S, Mannik M. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consist of autoantibodies to the collagen-like region of C1q. J Clin Invest 1988; 82: 816-824
24. Cook AD, Rowley MJ, Wines BD, Mackay IR. Antibodies to the collagen-like region of C1q and type II collagen are independent non-crossreactive populations in systemic lupus erythematosus and rheumatoid arthritis. J Autoimmun 1994; 7: 369-78
25. Rönnelid J, Gunnarsson I, Ekdahl-Nilsson K, Nilsson B. Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structually related autoantigens C1q and type II collagen in SLE or RA. J Autoimmun (in press)
26. Cederholm B, Wieslander J, Bygren P, Heinegård. Patients with IgA nephropathy have circulating anti-basement membrane antibodies reacting with structures common to collagen I, II, and IV. Proc Natl Acad Sci USA 1986; 83: 6151-6155
27. Cederholm B, Wieslander J, Bygren P, Heinegård. Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy. Proc Natl Acad Sci USA 1988, 85: 4865-4868
28. Abou-Ragheb HHA, Williams AJ, Brown CB, Milford-Ward A. Plasma levels of the anaphylatoxins C3a and C4a in patients with IgA nephropathy/Henoch-Schönlein nephritis. Nephron 1992; 62: 22-26
29. Uwatoko S, Gauthier J, Mannik M. Autoantibodies to the collagen-like region of C1q deposit in glomeruli via C1q in immune deposits. Clin Immunol Immunopathol 1991; 61: 268-273
30. Shena FP, Pastore A, Montinaro V. The role of polymeric IgA in complement-mediated solubilization of IgG and IgA immune complexes. Am J Kidney Dis 1988; 12: 433-436
31. Schifferli JA, Morris M, Dash A et al. Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis. Clin Exp Immunol 1981; 46: 557-564
32. Sinico RA, Fornasieri A, Oreni N, Benuzzi S, D'Amico G. Polymeric IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease). J Immunol 1986; 137(2): 536-541
33. Bowness P, Davies KA, Norsworthy PJ et al. Hereditary C1q deficiency and systemic lupus erythematosus. Q J Med 1994; 87: 455-464
34. Wyatt RJ, Julian BA, Rivas ML. Role for specific complement phenotypes and deficiencies in the clinical expression of IgA nephropathy. Am J Med Sci 1991; 301:115-123
35. Topaloglu R, Bakkaloglu A, Slingsby JH et al. Molecular basis of heriditary C1q deficiency associated with SLE and IgA nephropathy in a Turkish family. Kidney Int 1996; 50: 635-642